Matches in Wikidata for { <http://www.wikidata.org/entity/Q91001194> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91001194 description "article scientifique publié en 2019" @default.
- Q91001194 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91001194 description "scientific article published on 30 January 2019" @default.
- Q91001194 description "wetenschappelijk artikel" @default.
- Q91001194 description "наукова стаття, опублікована 30 січня 2019" @default.
- Q91001194 name "Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab" @default.
- Q91001194 name "Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab" @default.
- Q91001194 type Item @default.
- Q91001194 label "Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab" @default.
- Q91001194 label "Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab" @default.
- Q91001194 prefLabel "Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab" @default.
- Q91001194 prefLabel "Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab" @default.
- Q91001194 P1433 Q91001194-E2B21092-DA2C-49D9-9950-2BEBC66C1FA6 @default.
- Q91001194 P1476 Q91001194-A2C4A832-5BC2-4640-9E8E-62C1AD7B129D @default.
- Q91001194 P2093 Q91001194-02DB5D7E-6F39-4E94-9B38-4451A80FC971 @default.
- Q91001194 P2093 Q91001194-4B8F73EB-2E2F-4DA4-8AAC-E914DA1313E0 @default.
- Q91001194 P2093 Q91001194-65362152-DFF7-4A74-9395-442DAF6F7F30 @default.
- Q91001194 P2093 Q91001194-BACC0B62-4524-4563-8996-CFD790C3AA85 @default.
- Q91001194 P2093 Q91001194-E1DE1EFF-417A-430B-8ABA-8BBE0752671F @default.
- Q91001194 P304 Q91001194-83CF7F71-2E3F-4F9F-9104-677EC648FB8D @default.
- Q91001194 P31 Q91001194-D6F42021-ED95-4868-A1B1-EBB5E56D6687 @default.
- Q91001194 P356 Q91001194-8200E7C7-32B5-480D-BC36-0D252F15DFE2 @default.
- Q91001194 P433 Q91001194-212E3452-1BEC-430A-8322-AAD01BC60432 @default.
- Q91001194 P478 Q91001194-0E6D36A7-9337-4A8F-BDB2-32C623F84DDA @default.
- Q91001194 P50 Q91001194-A0A83ED7-7816-4695-8E70-312E8567436D @default.
- Q91001194 P577 Q91001194-6F1BC356-A242-4FB4-B837-CB216A038EFA @default.
- Q91001194 P698 Q91001194-2FE437E1-84FA-4814-B5CB-5CF7F2255256 @default.
- Q91001194 P356 ACS.MOLPHARMACEUT.8B01052 @default.
- Q91001194 P698 30633529 @default.
- Q91001194 P1433 Q3011140 @default.
- Q91001194 P1476 "Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab" @default.
- Q91001194 P2093 "Kohta Mohri" @default.
- Q91001194 P2093 "Qin Ren" @default.
- Q91001194 P2093 "Shota Warashina" @default.
- Q91001194 P2093 "Yasuhiro Wada" @default.
- Q91001194 P2093 "Yasuyoshi Watanabe" @default.
- Q91001194 P304 "1065-1073" @default.
- Q91001194 P31 Q13442814 @default.
- Q91001194 P356 "10.1021/ACS.MOLPHARMACEUT.8B01052" @default.
- Q91001194 P433 "3" @default.
- Q91001194 P478 "16" @default.
- Q91001194 P50 Q91001192 @default.
- Q91001194 P577 "2019-01-30T00:00:00Z" @default.
- Q91001194 P698 "30633529" @default.